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Abstract
Background: Colonization of the airways with potential pathogenic bacteria is observed in a number of chronic
respiratory diseases, such as COPD or cystic fibrosis. Infections with respiratory viruses are known triggers of
exacerbations of these diseases. We here investigated if pre-exposure to bacteria alters the response of lung
epithelial cells to subsequent viral infection.
Methods: Bronchial epithelial cells (BEAS-2B cells and primary bronchial epithelial cells) were exposed to
heat-inactivated Haemophilus influenzae, Pseudomonas aeruginosa or Streptococcus pneumoniae and subsequently
infected with respiratory syncytial virus (RSV), type 2 human adenovirus or influenza B. Levels of pro-inflammatory
cytokines, viral replication and expression of pattern recognition receptors were determined in culture supernatants
and/or cell lysates.
Results: Exposure of BEAS-2B cells to H. influenzae before and during RSV-infection synergistically increased the
release of IL-6 (increase above calculated additive effect at 72 h: 56 % ± 3 %, mean ± SEM) and IL-8 (53 % ± 12 %).
This effect was sustained even when bacteria were washed away before viral infection and was neither associated
with enhanced viral replication, nor linked to increased expression of key pattern recognition receptors. P.
aeruginosa enhanced the release of inflammatory cytokines to a similar extent, yet only if bacteria were also present
during viral infection. S. pneumoniae did not enhance RSV-induced cytokine release. Surprisingly, adenovirus
infection significantly reduced IL-6 release in cells exposed to either of the three tested bacterial strains by on
average more than 50 %. Infection with influenza B on the other hand did not affect cytokine production in
BEAS-2B cells exposed to the different bacterial strains.
Conclusion: Pre-exposure of epithelial cells to bacteria alters the response to subsequent viral infection depending
on the types of pathogen involved. These findings highlight the complexity of microbiome interactions in the
airways, possibly contributing to the susceptibility to exacerbations and the natural course of airway diseases.
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Background
Infections of the respiratory tract are a major risk to
patients with chronic respiratory diseases, such as chronic
obstructive pulmonary diseases (COPD). The majority of
acute exacerbations of COPD (AECOPD) is associated
with an acute respiratory infection, with viral and/or
bacterial pathogens being detected in more than half of all
exacerbations [1, 2]. Experimental infections of COPD
and asthma patients with human rhinoviruses (HRV) have
moreover provided evidence for a causal relationship be-
tween an acute infection and the onset of symptoms char-
acteristic for acute exacerbations in both diseases [3, 4].
Other viruses that are detected during AECOPD include
respiratory syncytial virus (RSV), influenza viruses and
adenovirus strains [5, 6].
Next to viral infection, also bacterial infections can be
involved in the development of acute exacerbations.
Among the bacterial species that are frequently detected
during such episodes are strains of non-typeable (NT)
Haemophilus influenzae, Pseudomonas aeruginosa and
Streptococcus pneumoniae [1]. Importantly, colonization
with these bacteria is also frequently observed in the
stable state of the disease. Potential pathogenic microor-
ganisms (PPMs) have been detected in approximately
25 % of COPD patients during stable disease, even when
rather insensitive culture-dependent techniques were
employed [7–10]. Likewise, increased load of PPMs has
also been described for other chronic lung diseases, such
as asthma and cystic fibrosis [11–13].
Not only is bacterial colonization associated with an
increased risk to develop an acute exacerbation, it is also
associated with increased levels of inflammatory markers
in the stable state [14–16]. Furthermore, pro-inflammatory
cytokines, such as IL-6 and IL-8, have been shown to be
elevated in the sputum of frequent exacerbators and during
exacerbation [17]. Changes in IL-6 between stable state
and exacerbation were found to be particularly pro-
nounced, if the exacerbations were associated with a viral
infection [17–19].
AECOPD associated with the detection of a combin-
ation of bacterial and viral pathogens have been reported
to be particularly severe in terms of inflammation and
decline in lung function [20]. Moreover, these events on
average required longer hospitalizations [2]. Presence of
both, potential pathogenic bacteria and viruses, during the
same period of exacerbations have been observed in as
much as 12 to 25 % of AECOPD [21, 22]. When specific-
ally looking at AECOPD associated with a positive culture
of NT H. influenzae, almost half of the patients were also
tested positive for at least one respiratory virus [23].
Considering these studies made use of rather insensitive
conventional culturing techniques to detect bacteria, these
numbers are most likely even underestimating the preva-
lence of simultaneous presence of bacteria and viruses.
Numerous studies have investigated how primary viral
infections increase susceptibility to secondary bacterial
infections, for example by disrupting epithelial barriers
[24], increasing bacterial attachment or colonization
[25–28], or modulating innate and adaptive immune
responses [29–33]. On the other hand, consequences of
a primary exposure to bacteria on the outcome of sec-
ondary viral infections have been less extensively studied
[34]. Considering the substantial proportion of patients
chronically colonized with bacteria, this concept might -
though less well understood - be equally important.
We therefore hypothesized that the response of airway
epithelial cells to respiratory viral infections is influenced
by pre-exposure to bacterial pathogens. In the present
study we investigated how exposure to different respira-
tory bacteria influences the inflammatory response and
susceptibility of respiratory epithelial cells to a secondary
infection with respiratory syncytial virus (RSV), influ-
enza B virus and adenovirus.
Methods
Cell culture
BEAS-2B cells (ATCC CRL-9609) were cultured in RPMI-
1640 (life technologies, Carlsbad, USA) supplemented with
10 % fetal bovine serum (FBS; Lonza, Basel, Switzerland).
For experiments, BEAS-2B cells were used for up to 15
passages after cryopreservation (passage number 20 to 35).
Culture flasks and multiwell plates were pre-coated with a
mixture of bovine collagen (30 μg/ml), human fibronectin
(10 μg/ml; both BD Biosciences, San Jose, USA) and bovine
serum albumin (BSA, 10 μg/ml, Sigma Aldrich, St Louis,
USA). For experiments, BEAS-2B cells were seeded at 105
cells per well in collagen/fibronectin-coated 48-well plates
the day before the experiment. Cell layers were approxi-
mately 80–90 % confluent at the start of the experiment.
Primary bronchial epithelial cells (pBECs) were kindly
provided by the Primary Lung Cell (PLUC) facility Maas-
tricht University Medical Center + (MUMC+, Maastricht,
The Netherlands). Lung tissue used for the isolation of
pBECs was obtained from the Maastricht Pathology Tissue
Collection (MPTC) and originated from tissue resected
during lobectomies or pneumonectomies of patients who
underwent surgery for lung cancer. Collection, storage and
use of tissue and patient data were performed in agreement
with the “Code for Proper Secondary Use of Human Tissue
in the Netherlands” (http://www.fmwv.nl). The scientific
board of the MPTC approved the use of materials for this
study under code MPTC2010-019. PBECs were isolated
from bronchus rings that were macroscopically free of
cancer. Isolation, culture and characterization of cells was
performed as previously described [35]. Epithelial character
of the cells was confirmed by immunohistochemical
staining for cytokeratins 5, 6, 8 and 17. Experiments were
performed on cells isolated from seven donors. All donors
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(median age 67 years, range 55–78 years) were never-
smokers or former smokers, and had not been diagnosed
with COPD, cystic fibrosis or asthma.
For the seeding of pBECs, the methodology was adapted
to account for different generation times of cells derived
from different donors and to meet growth requirements of
the primary cells. PBECs were seeded at 1.5 × 104 cells per
well in pre-coated 24-well plates in B/D medium consisting
of 50 % DMEM (life technologies) and 50 % Bronchial Epi-
thelial Basal Medium (BEBM; Lonza), supplemented with
bronchial epithelial growth medium (BEGM) singlequots
(Lonza), and BSA (1.5 mg/ml, Sigma Aldrich). Experiments
were started once cell layers reached approximately 80 %
confluence.
Virus culture
Virus strains were provided by the Dutch National Institute
for Public Health and the Environment (RIVM, Bilthoven,
the Netherlands).
RSV (strain A2) was propagated in Vero cells and con-
centrated by precipitation in polyethyleneglycol 6000 as
described previously [36]. Influenza B (Yamagata lineage)
were propagated in MDCKII cells. Human adenovirus 2
was propagated in HeLa cells.
The infectivity of viruses was quantified by determining
the 50 % Tissue Culture Infective Dose (TCID50) using
the Spearman Karber Method [37].
Bacterial culture
All bacterial strains used in this study were reference strains
obtained from ATCC and were cultured at 37 °C and 5 %
CO2. NT H. influenzae (ATCC 49247) was cultured on
Vitox-supplemented chocolate agar plates (Oxoid, Wesel,
Germany). P. aeruginosa (ATCC 27853) and S. pneumoniae
(ATCC 49619) were cultured on B/D Columbia blood agar
plates (Becton Dickinson, Franklin Lakes, USA).
Infection protocols
Preparation of inactivated bacterial suspensions
Bacterial suspensions were prepared by adding several
colonies of an overnight culture to RPMI-1640 medium.
These suspensions were heat-inactivated at 65 °C for 1 h.
Inactivation was confirmed by plating out aliquots of the
suspension on agar plates. Bacteria were then pelleted by
centrifugation at 4500 x g for 10 min, washed once with
PBS and re-suspended in infection medium. The compos-
ition of the infection medium was dependent on the cell
type and virus used. Stimulation and infection of BEAS-2B
cells with bacteria in combination with RSV and adenovirus
was performed in RPMI-1640 supplemented with 2 % FBS
(Lonza). For subsequent infection with Influenza B, bacter-
ial suspensions were prepared in serum-free medium con-
sisting of Minimal Essential Medium (life technologies)
supplemented with 1 mg/ml proteose peptone, 0.1 mg/ml
BSA, 0.2 mg/ml D-glucose monohydrate (all Sigma Aldrich,
St Louis, USA) and 0.05 ‰ trypsin/EDTA (life technolo-
gies). For experiments on primary cells, infection medium
consisted of B/D medium supplemented with BEGM
singlequots (both Lonza) except human epidermal growth
factor and bovine pituitary extract. The turbidity of the bac-
terial suspensions was adjusted to 0.5 McFarland (equiva-
lent to approximately 1.5 × 108 cfu/ml).
Continuous stimulation
Bacterial suspensions were further diluted 1:10 in infec-
tion medium. Cells were first stimulated with bacteria
for 4 h, and subsequently infected with the respective
virus. For virus infection, culture supernatants were
aseptically collected from each well and preserved while
cells were exposed for one hour to diluted virus to yield
a multiplicity of infection (MOI) of one. After this initial
attachment period, cells were washed once with PBS and
the original culture medium (including bacteria) was
added to back the wells.
Pre-exposure protocol
Bacterial suspensions of 0.5 McFarland were prepared as
described above. For stimulation of cells, 0.5 ml of the
bacterial suspension or control medium were added to
each well. After 24 h of exposure, cell layers were washed
with PBS and infected with RSV at an MOI of one. Virus
particles were allowed to attach for 1 h, after which un-
bound virus was aspirated, cells layers were washed with
PBS and fresh medium was added to the wells.
Cell-free supernatants and cell lysates were collected
24, 48 and 72 h after viral infection and stored at −80 °C
until use.
ELISA
Levels of IL-6 and IL-8 were determined using an enzyme
linked immunosorbent assay (ELISA) according to the
manufacturer’s instructions (Ready-SET-Go, eBioscience,
San Diego, USA). Lower limits of detection were 2.4 pg/
ml for IL-6 and 3.2 pg/ml for IL-8.
Determination of RSV RNA copies
Total RNA from cell lysates was isolated using the
FavorPrep Tissue Total RNA purification kit (Favorgen,
Pingtung, Taiwan). Remaining genomic DNA was degraded
by DNase treatment (Ambion Turbo DNAfree, life tech-
nologies). For each sample, 500 ng of total RNA was re-
verse transcribed using the iScript cDNA synthesis kit (Bio-
Rad, Hercules, USA). Real-time PCR was then performed
on a MyIQ real-time PCR system (Bio-Rad) using the fol
lowing primers: Forward 5′- TTTCCACAATATYTAAGT
GTCAA-3′; Reverse 5′- TCATCWCCATACTTTTCTGT
TA-3′. Viral RNA copy numbers were calculated by using a
standard curve derived from in vitro transcribed RSV RNA.
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Statistical analyses
Statistical analysis was performed using Prism 5 (Graph-
Pad, La Jolla, USA) and SPSS 22.0 (IBM, Armonk, USA).
Data are presented as mean ± standard error of the mean
(SEM) of five to seven independent experiments. For
better visualization of the synergistic effects, the additive
effect of two pathogens is indicated as a dashed line in
some graphs. This theoretical additive effect for a given
combination of pathogens was calculated as the sum of
cytokine levels of the individual infections. Statistical sig-
nificance of bacterial and viral challenges, as well as in-
teractions between the two, were determined using a
two way analysis of variance (ANOVA) and a Bonferroni
post-hoc analysis. To determine statistical significance of
bacterial-viral interactions in primary epithelial cells,
relative changes over the additive effect were calculated
and tested for statistical significance using a one sample
t-test. Differences in viral RNA copies and infectious
particles were tested for statistical significance using a
one-way ANOVA. In all cases, effects were considered
statistically significant if p < 0.05.
Results
H. influenzae and P. aeruginosa synergistically enhance
the release of the pro-inflammatory cytokines IL-6 and
IL-8 during RSV infection
We first investigated if exposure to respiratory bacter-
ial pathogens can alter the epithelial response to sub-
sequent RSV infection. To this end, we made use of
the immortalized bronchial epithelial cell line BEAS-2B,
which is frequently used to study airway epithelial
responses to pathogens and displays similar expression of
pattern recognition receptors (PRRs) as primary bronchial
epithelial cells [38]. BEAS-2B cells were stimulated with
heat-inactivated preparations of NT H. influenzae, P. aeru-
ginosa or S. pneumoniae. Four hours later, cells were
additionally infected with RSV and secretion of IL-6 and
IL-8 was monitored over a total period of 72 h.
Exposure of cells to heat-inactivated H. influenzae or
P. aeruginosa caused significant release of the pro-
inflammatory cytokines IL-6 and IL-8, as did infection
with RSV alone. When cells were first exposed to heat-
inactivated H. influenzae (Fig. 1a) or P. aeruginosa
(Fig. 1b) and subsequently infected with RSV, IL-6 re-
lease was synergistically increased: Seventy-two hours
after infection, experimentally determined values of IL-6
in the culture supernatants were on average increased by
56 ± 3 % (H. influenzae) or 46 ± 9 % (P. aeruginosa) com-
pared to the sum of cytokines released by either bacteria
or virus alone (indicated as bacteria + virus (theoretical),
dashed line). For S. pneumoniae on the other hand, there
was no significant interaction of bacteria and virus on
the induction of IL-6 release at any of the assessed time
points (Fig. 1c). Of note, the cytokine response of BEAS-
2B cells to heat-inactivated pneumococci was clearly
lower than the cells’ response to the other two tested
bacterial species and there was no significant effect of S.
pneumoniae exposure on cytokine release (Fig. 1c, f ).
A B C
D E F
Fig. 1 Co-stimulation of epithelial cells with bacteria and virus potentiates inflammatory cytokine release. BEAS-2B cells were first exposed
to heat-inactivated preparations of non-typeable (NT) H. influenzae (a, d), P. aeruginosa (b, e) or S. pneumoniae (c, f) for 4 h and subsequently
infected with RSV and incubated for up to 72 h in the presence of bacteria. Concentrations of IL-6 (a–c) and IL-8 (d–f) in culture supernatants
were determined by ELISA. The theoretical additive effect (dashed line) was calculated as the sum of bacteria and virus-induced cytokine secretion.
Symbols indicate a statistically significant effect of bacteria alone (*), virus alone (#) and a significant interaction between bacteria and virus (&) as
determined by Two Way Repeated Measures ANOVA (p < 0.05). hpi: hours post viral infection
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Similar to IL-6, also IL-8 release was synergistically en-
hanced in cells infected with RSV in the presence of ei-
ther H. influenzae (Fig. 1d) or P. aeruginosa (Fig. 1e),
whereas we did not detect a significant interaction of S.
pneumoniae with this virus (Fig. 1f ).
RSV and H. influenzae also synergistically increased IL-6
release when applied in the reverse order, i.e., when cells
were first infected with RSV and subsequently co-stimulated
with heat-inactivated bacteria, suggesting interactions
between the two pathogens are not exclusive to primary
bacterial stimulation (data not shown). However, since we
were primarily interested in the effect of a primary bacterial
exposure (as a model for bacterial colonization) on second-
ary viral infections, all results presented here are derived
from experiments in which cells were first exposed to
bacteria and subsequently infected with virus.
Stimulation with heat-inactivated bacteria and/or RSV
did not significantly affect metabolic activity of the cells;
differences in cytokine secretion were thus unlikely to be
caused by pathogen-specific effects of the treatments on
cell viability (Additional file 1: Figure S1A).
Due to the limited possibilities for bacterial control or
clearance in our in vitro setting, inactivating the bacterial
suspension was inevitable to avoid bacterial overgrowth of
the epithelial cultures during the 3 day experimental period.
To exclude any effect of the mode of inactivation on our
readouts, we repeated the experiments using a low dose of
gentamicin (4 μg/ml) to inhibit growth of H. influenzae, in-
stead of heat-inactivating the bacteria. Although the results
failed to meet statistical significance, we still observed a
trend towards a synergistic interaction between H. influen-
zae and RSV on IL-6 release (mean increase 65 % ± 39 %, p
= 0.065; Additional file 1: Figure S1B).
Pre-exposure of cells to heat-inactivated H. influenzae is
sufficient to synergistically increase RSV-induced cytokine
release
Several respiratory viruses, including RSV, have previ-
ously been shown to enhance attachment of a variety of
bacterial species to cells of the respiratory tract [27, 28,
39–41]. Due to the prolonged incubation during which
the cells are exposed to both pathogens (bacteria and vi-
ruses), it cannot be excluded that viral infection
enhances bacterial binding also in our experimental set-
ting. Such augmented bacterial attachment and con-
comitant enhanced recognition might also explain an
increased inflammatory response. In a second set of ex-
periments, we therefore investigated if the altered in-
flammatory response of co-stimulated cells required the
presence of bacteria during viral infection.
Cells were pre-exposed to bacteria for 24 h, after
which cell layers were washed thoroughly with PBS and
infected with RSV. This pre-exposure of cells to H.
influenzae was sufficient to synergistically increase RSV-
induced IL-6 release at all assessed time points. Pre-
exposure also increased IL-8 release after subsequent
infection with RSV, with the interaction reaching statis-
tical significance at 72 h after infection and a trend to-
wards statistical significance at the earlier time points
(24 h: p = 0.077; 48 h: p = 0.089; Fig. 2d).
In cells pre-exposed to P. aeruginosa before RSV-
infection, we only detected a small, yet statistically signifi-
cant synergistic effect on IL-6 production 24 h after
infection (mean increase over additive effect 8 % ± 2 %, p =
0.002), but not at the later time points (Fig. 2b). IL-8 secre-
tion in response to RSV, however, was still synergistically
enhanced after pre-exposure of cells to P. aeruginosa at
72 h after infection (Fig. 2e). In line with the results ob-
tained from a continuous exposure to bacteria, pre-
exposure of cells to heat-inactivated preparations of S.
pneumoniae did not significantly affect cytokine release
after RSV infection (Fig. 2 c and f). As for the continuous
exposure protocol, also during the pre-exposure protocol
there was no evidence for a significant effect of the treat-
ments on cell viability (Additional file 1: Figure S1C).
Taken together, these results indicate that pre-exposure
of cells with NT H. influenzae, is sufficient to potentiate
RSV-induced cytokine release and that continuous pres-
ence of bacteria is not required. The increased inflamma-
tory response of cells pre-exposed to NT H. influenzae
was thus unlikely to be triggered by enhanced bacterial at-
tachment to the cells.
Influence of previous exposure to bacteria on
RSV-induced IL-6 production by primary bronchial
epithelial cells
We next sought to confirm our findings in primary bron-
chial epithelial cells (pBECs). Therefore, bronchial epithelial
cells were isolated from seven non-smoking individuals
without chronic respiratory diseases such as COPD, asthma
or cystic fibrosis (median age 67 years; range 55–78 years).
Presence of chronic respiratory diseases was excluded based
on medical history, pulmonary function tests and imaging.
The cells were treated with suspensions of heat-inactivated
bacteria and subsequently infected with RSV according to
the pre-exposure protocol described in the Methods section
of this article.
Cytokine release, particularly in response to RSV infec-
tion, varied considerably between cells from different do-
nors (Table 1).
In order to account for inter-individual variability, results
in Fig. 3 are expressed as percent changes relative to a
calculated additive effect (i.e., relative to the sum of cyto-
kine concentrations released in response to each pathogen
alone) for each donor. Pre-exposure to H. influenzae
increased RSV-induced IL-6 release by cells from four out
of seven donors above this additive effect (Fig. 3a). Likewise,
pre-exposure to P. aeruginosa synergistically enhanced the
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IL-6 release following RSV infection in four out of
seven donors, with a trend towards statistical signifi-
cance 72 h after infection (p = 0.09, Fig. 3b). More-
over, and also in line with the results obtained in
BEAS-2B cells, S. pneumoniae did not further
increase IL-6 release after RSV-infection in pBECs
(Fig. 3c). In contrast, however, pre-exposure of
pBECs to either bacterial species did not significantly
affect virus-induced IL-8 secretion (data not shown).
Up to 48 h after viral infection, there was no effect
of the treatments on metabolic activity of pBECs;
Seventy-two hours after infection, cell viability was
modestly decreased in virus-infected cells, yet there
were no differences between cells pre-treated with
the different bacteria that would explain altered
cytokine secretion (Additional file 1: Figure S1D).
Enhanced release of inflammatory mediators is not linked
to enhanced viral replication
Exposure to bacterial pathogens has previously been sug-
gested to enhance viral attachment and replication in lung
epithelial cells [36, 42]. We therefore tested if the enhanced
inflammatory response of BEAS-2B cells towards RSV after
pre-exposure with bacteria was due to enhanced viral
replication. Neither intracellular viral RNA levels (Fig. 4a)
nor the release of infectious progeny (Fig. 4b) was signifi-
cantly altered when cells were pre-exposed to either of the
three bacteria used in this study. Nevertheless, viral replica-
tion seemed at least indirectly to be required to potentiate
cytokine release, since H. influenzae in combination with
UV-inactivated virus did not cause increased secretion of
IL-6 (Additional file 1: Figure S1E). In agreement with this,
synergy between the pathogens was most pronounced after
Table 1 IL-6 release by pBECs pre-exposed to heat-inactivated bacteria and subsequently infected with RSV
24 hpi 48 hpi 72 hpi
- RSV + RSV - RSV + RSV -RSV + RSV
ctrl 6.1 ± 1.1 179.1 ± 77.2 8.4 ± 2.6 208.5 ± 83.3 6.6 ± 1.8 234.3 ± 91.6
+hiNTHI 8.4 ± 1.6 206.8 ± 88.0 11.4 ± 2.6 258.7 ± 116.3 10.3 ± 2.7 324.2 ± 147.3
+hiPA 19.5 ± 14.9 225.0 ± 123.0 21.4 ± 16.3 288.7 ± 120.6 18.6 ± 13.9 335.3 ± 139.7
+hiSP 4.5 ± 0.9 177.8 ± 74.8 6.0 ± 1.7 210.0 ± 88.0 6.2 ± 1.6 238.7 ± 100.1
Values are given in pg/ml and represent the mean ± SEM (n = 7). hpi: hours post (viral) infection, hi heat-inactivated, NTHI non-typeable H. influenzae, PA P.
aeruginosa, SP S. pneumoniae, RSV respiratory syncytial virus
A B C
D E F
Fig. 2 Pre-exposure of cells to NT H. influenzae increases production of inflammatory cytokines upon RSV infection. BEAS-2B cells were first
exposed to heat-inactivated preparations of non-typeable (NT) H. influenzae (a, d), P. aeruginosa (b, e) or S. pneumoniae (c, f) for 24 h, after which
bacteria were washed away and cells were infected with RSV for up to 72 h. Concentrations of IL-6 (a–c) and IL-8 (d–f) in culture supernatants
were determined by ELISA. The theoretical additive effect (dashed line) was calculated as the sum of bacteria and virus-induced cytokine secretion.
Symbols indicate a statistically significant effect of bacteria alone (*), virus alone (#) and a significant interaction between bacteria and virus (&) as
determined by Two Way Repeated Measures ANOVA (p < 0.05). hpi: hours post viral infection
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cells mounted a cytokine response against the virus itself,
i.e., at 48 h after viral infection and later.
To test if exaggerated inflammation was linked to in-
creased expression of key PRRs involved in the recognition
of bacterial and/or viral structures, we next measured
mRNA levels of TLR2, TLR3, TLR4 and RIG-I. However,
there was no significant interaction between bacteria and
viruses on the expression levels of any of these genes
(Additional file 1: Figure S2).
Changes in the virus-induced inflammatory response after
bacterial pre-exposure are species-specific
Because of the pathogen-specificity we observed when
investigating different bacteria in combination with RSV,
we next evaluated the inflammatory response of bacterially
challenged epithelial cells during infection with different
viruses. Next to RSV, rhinoviruses, influenza viruses and
specific adenoviruses are among the most frequently de-
tected respiratory viral pathogens [5, 43]. Since the influ-
ence of bacterial exposure on infection with human
rhinovirus has already been the subject of previous studies
[36, 42], we now assessed combinations of different bacteria
with influenza B virus and a type 2 human adenovirus.
In our hands, infection with influenza B virus only in-
duced modest IL-6 release (Fig. 5 a–c). Although we found
a statistically significant interaction between H. influenzae
and influenza B virus (measured cytokine levels lower than
the calculated additive effect 24 and 72 h after infection), as
well as between P. aeruginosa and influenza B (measured
cytokine levels lower than the calculated additive effect at
all time points), co-stimulated cells still released cytokines
at levels comparable to those of cells stimulated with
bacteria only.
Human adenovirus on the other hand did not induce IL-
6 production by itself, but significantly reduced cytokine
release induced by the different bacteria. When compared
to the additive effect of the pathogens, stimulation of cells
with adenovirus after bacterial exposure reduced IL-6
release at 72 h by 57 % ± 6 % in combination with NT H.
influenzae (Fig. 5d) and 68 %± 4 % in combination with P.
aeruginosa (Fig. 5e). For IL-8, there was a significant inter-
action between all three bacteria in combination with
human adenovirus 72 h after viral infection. Measured IL-8
levels were on average 39 % ± 9 % (for NT H. influenzae),
42 % ± 4 % (for P. aeruginosa) and 83 %± 2 % (for S. pneu-
moniae) below the additive effect of these pathogens.
In summary, the effect of subsequent challenges with
bacteria and viruses on release of inflammatory media-
tors was not only dependent on the bacterial species




Fig. 3 Exposure of pBECs to NT H. influenzae or P. aeruginosa enhances IL-6 release. PBECS of seven donors were pre-exposed to heat-inactivated
preparations of non-typeable (NT) H. influenzae (a), P. aeruginosa (b), or S. pneumoniae (c) for 24 h, after which bacteria were washed away and
cells were infected with RSV for up to 72 h. IL-6 levels in culture supernatants 24, 48 and 72 h after viral infection were determined by ELISA. Due
to considerable inter-individual variation in absolute cytokine levels, data are shown as relative changes of experimentally determined cytokine
concentrations over the theoretical additive effect for each donor. Results obtained using cells from each donor are denoted with the same
symbol in all datasets. hpi: hours post viral infection
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Discussion
H. influenzae is the most commonly found PPM in the
lower respiratory tract of COPD patients. We here dem-
onstrate that exposure of the bronchial epithelial cell
line BEAS-2B to heat-inactivated H. influenzae signifi-
cantly augments RSV-induced release of the pro-
inflammatory cytokines IL-6 and IL-8. H. influenzae has
previously been described to enhance the secretion of
IL-8 in response to certain strains of another major re-
spiratory virus, human rhinovirus (HRV), by up-
regulating expression of TLR3 [42]. In our experimental
model of bacterial exposure and RSV-infection, the syn-
ergy between heat-inactivated H. influenzae and RSV on
the release of pro-inflammatory cytokines was not
reflected in the expression levels of TLR3, or other pat-
tern recognition receptors (PRRs) relevant for the detec-
tion of RSV and/or H. influenzae [44–47].
Increased bacterial or viral binding is considered a
major feature in the pathogenesis of polymicrobial infec-
tions. RSV infection has previously been described to pro-
mote fimbriae-mediated attachment of H. influenzae to
epithelial cells [41, 48]. However, considering that the pro-
inflammatory effects of pre-exposure to heat-inactivated
H. influenzae were sustained even when unbound bacteria
were washed away prior to RSV infection, the increased
release of IL-6 and IL-8 is most likely not a consequence
of greater bacterial binding. Conversely, exposure of lung
epithelial cells to H. influenzae has been shown to increase
the cells’ susceptibility to secondary infection with major
group HRV by upregulating their cellular entry receptor,
ICAM-1 [36, 42]. Although neutralizing antibodies for
ICAM-1 can reduce RSV infection in vitro, it is not the
main functional receptor for this virus [49, 50]. Corres-
pondingly, the exaggerated inflammation we observed in
our model was not linked to increased viral endpoint titers
nor increased levels of intracellular viral RNA, suggesting
alterations in intra- or intercellular signaling rather than a
generalized increase in viral replication as a cause. Never-
theless, viral replication was at least indirectly required,
since UV-inactivated virus did not further increase the se-
cretion of inflammatory cytokines in our experimental
model. Interestingly, treatment of epithelial cells with
heat-killed H. influenzae can reduce bacterial and fungal
burden after secondary infection with several pathogens,
and also limit influenza virus replication in a mouse model
of influenza virus pneumonia [51, 52]. Effectiveness
against other viruses has yet to be evaluated, but was not
evident for RSV in our model.
Similar to H. influenzae, also P. aeruginosa elicited a
strong increase in the secretion of pro-inflammatory cy-
tokines IL-6 and IL-8, and like H. influenzae, potentiated
RSV-induced cytokine release. However, in BEAS-2B
cells, continuous presence of P. aeruginosa during viral
infection was required to observe a sustained synergistic
effect on IL-6 release. P. aeruginosa and RSV have been
described to interact directly and RSV has hence been
suggested as a coupling agent between bacteria and cells,
thus enhancing bacterial attachment [53]. Such an inter-
action might explain the diverging results we obtained
using different exposure protocols.
The third bacterial pathogen we investigated in this study
was S. pneumoniae, a Gram-positive opportunistic patho-
gen of the respiratory tract. In our experimental setting,
heat-inactivated preparations of S. pneumoniae did not
increase secretion of IL-6 or IL-8. This lack of an epithelial
reaction towards S. pneumoniae might be attributable to
the fact that we used heat-inactivated preparations of
bacteria, preventing the expression of important virulence
A
B
Fig. 4 Pre-exposure of cells to bacteria has no significant effect
on RSV replication. BEAS-2B cells were exposed to heat-inactivated
bacteria for 24 h, after which cell layers were washed and infected
with RSV for another 72 h. a Intracellular RSV RNA copies were
determined by real-time PCR. b Release of infectious progeny in
culture supernatants was measured by determining the TCID50. NTHI:
non-typeable H. influenzae, PA: P. aeruginosa, SP: S. pneumoniae, n.s.:
not significant
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factors. Also, we did not observe a consistent significant
interaction between S. pneumoniae and RSV in our model
in terms of eliciting an inflammatory response. Import-
antly, RSV has recently been found to directly interact
with S. pneumoniae [54]. Bacterial binding to the viral G
protein triggered profound alterations in the bacterial
transcriptome and lead to increased expression of a set of
virulence factors. Unfortunately, in our experimental set-
ting inactivation of bacteria was inevitable to prevent bac-
terial overgrowth and synergistic effects of S. pneumoniae
and RSV might therefore be obscured. Altered bacterial
virulence due to direct interactions between pathogens
adds another layer of complexity to the study of polymi-
crobial infections.
Our experiments in pBECs revealed considerable inter-
individual differences between cells from different donors,
not only in terms of absolute cytokine concentrations, but
also with respect to the effect of bacterial exposure on
subsequent infection. Although we aimed to include pBEC
donors of a relatively homogenous group in terms of age,
smoking-status and the absence of COPD, asthma and
cystic fibrosis as underlying pulmonary diseases, differences
that arise due to their clinical background or the isolation
procedure cannot fully be excluded as a source of variabil-
ity. Notably, cytokine release was evidently lower in primary
cells than in BEAS-2B cells, particularly in response to
bacteria. This less responsive phenotype might contribute
to the differences we observed between primary cells and
the immortalized cell line. Nonetheless, at 72hpi, results ob-
tained with cells from four out of seven donors were in line
with the data obtained in BEAS-2B cells, showing a more
than additive effect of pre-exposure with H. influenzae or P.
aeruginosa and RSV infection.
The effect of an exposure to bacteria prior to viral infec-
tion on cellular inflammatory responses was not only
dependent on the bacterial species, but was also virus-
specific. Cells exposed to bacteria and subsequently infected
with influenza B still released cytokine levels comparable to
those of cells exposed to bacteria alone. Even though
secondary bacterial infection is a major contributor to influ-
enza virus pathology the reverse order of sequential infec-
tions does not seem to have such detrimental effects [34].
This is in line with previous data by Lee et al., who demon-
strated a lack of effect on the course of the disease when
mice were exposed to H. influenzae type b before an influ-
enza challenge, despite a strong lethal synergism when mice
were infected in the reverse order [55]. Application of H.
influenzae lysates can even confer a temporary protection
against subsequent influenza infection by boosting local
innate responses [52].
In contrast, cytokine levels produced by cells infected
with adenovirus after an initial bacterial exposure were sig-
nificantly reduced. Decreased levels of IL-6 and IL-8 after
exposure to bacterial stimuli in combination with adeno-
virus might be attributed to the adenoviral proteins E1A
and E1B, which have previously been reported to reduce
A B C
D E F
Fig. 5 Co-stimulation of cells with bacteria and viruses influences cytokine release in a pathogen-specific manner. BEAS-2B cells were first
pre-exposed to either NT H. influenzae (a, d), P. aeruginosa (b, e) or S. pneumoniae (c, f) for 4 h and subsequently infected with Influenza B (a–c)
or Adenovirus (d–f) for up to 72 h in the presence of bacteria. Concentrations of IL-6 in culture supernatants were determined by ELISA. The
theoretical additive effect (dashed line) was calculated as the sum of bacteria and virus-induced cytokine secretion. Symbols indicate a statistically
significant effect of bacteria alone (*), virus alone (#) and a significant interaction between bacteria and virus (&) as determined by Two Way
Repeated Measures ANOVA (p < 0.05). hpi: hours post viral infection
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the induction of IL-6 in response to bacterial and inflam-
matory stimuli in human epithelial cells [56, 57].
Using an in vitro model of bronchial epithelial cells
allowed us to investigate pathogen specific interactions
in a controlled environment. Being the first tissue to be
exposed to infectious particles, the airway epithelium is
crucial for initiating a first immune response. However,
the possibilities to mimic a chronic exposure to bacteria,
as would be the case during a bacterial colonization of
the lungs, are limited in vitro. Therefore, more studies
are needed to examine, for example, the impact of
immune cells and the development of tolerance in this
context. Extrapolating biological significance from the
magnitude of an effect observed in vitro may be difficult.
In a model of bacterial co-colonization, Ratner et al.
showed that interactions of pathogens on the release of
cytokines in vitro which were in a similar order of magni-
tude as the ones we observed in our study, could indeed
translate to a biologically relevant effect in vivo [58].
Even though culture-dependent techniques usually only
revealed a limited number of bacterial genera in the lower
respiratory tract of colonized individuals, molecular tech-
niques suggest that the lung microbiota is in fact far more
complex. Furthermore, changes in the lung microbiome in
asthma and COPD have been reported in several studies
[59–61]; particularly pathogenic proteobacteria, such as
H. influenzae, were more frequently found in the lungs of
patients suffering from these diseases than in control sub-
jects. It can be assumed that not only the presence of cer-
tain bacterial species, but also the composition of the local
microbiota in the respiratory tract affects the response to-
wards viral pathogens. In view of the pathogen-specific ef-
fects we observed in our study, it would therefore be
interesting to expand this concept further towards a more
complex representation of the lung microbiome in health
and disease.
Conclusions
We show that pre-exposure of airway epithelial cells to
heat-inactivated NT H. influenzae and P. aeruginosa
aggravates the production of pro-inflammatory cytokines
in response to subsequent infection with RSV, but not
influenza B virus or adenovirus. Taken together, our data
provide experimental evidence for the pleiotropic effects
of microbial interactions on pulmonary inflammation. If
these findings can be translated into the clinical setting,
it might enable clinicians to identify patients at high risk
for developing more severe viral infections on the basis
of their bacteriological status.
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